Literature DB >> 6604846

Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures.

R M Engelman, B Haag, S Lemeshow, A Angelo, J H Rousou.   

Abstract

Nineteen patients undergoing coronary revascularization (14 patients) or valve replacement (five patients) were studied to monitor the catecholamine levels following operation and for each of three consecutive postoperative days. A significant (p less than 0.01) elevation was observed in both the serum norepinephrine and epinephrine levels immediately following operation, with both responding in a similar fashion (r = 0.804, p = 0.016). While epinephrine returned to control levels within 3 days of operation, the norepinephrine levels remained above control. The elevation in catecholamines associated with cardiac operation is presumed to be secondary to (1) the stress of surgical trauma and (2) the influence of cardiopulmonary bypass, with its attendant hypothermia and hemodynamic alterations. A comparative analysis was performed of (1) the type of operation, (2) the sex of the patient, (3) the presence of postoperative arrhythmia, (4) the history of receiving propranolol, (5) the duration of cardiopulmonary bypass, (6) the duration of operation, and (7) the volume of fluid gradient absorbed during operation. None of these parameters except the sex of the patient was significantly related to the change in either norepinephrine or epinephrine associated with the operation. There was a significantly (p less than 0.05) higher epinephrine level at day 2 and 3 following operation in women than in men. None of the 19 patients had postoperative complications except for arrhythmias, which developed in nine patients and were not associated with the catecholamine responses. It is concluded that peak catecholamine stimulation does not reflect the ease of postoperative recovery. The duration of bypass and operation were also not directly related to the level of stimulation. It is apparent that there are multiple factors which combine to influence catecholamine secretion during cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604846

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Plasma catecholamine changes during cardiopulmonary bypass: a randomised double blind comparison of trimetaphan camsylate and sodium nitroprusside.

Authors:  L Corr; R M Grounds; M J Brown; J G Whitwam
Journal:  Br Heart J       Date:  1986-07

2.  Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial.

Authors:  T J Campbell; T P Gavaghan; J J Morgan
Journal:  Br Heart J       Date:  1985-07

Review 3.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

Review 4.  Serotonin and acute cardiovascular disorders.

Authors:  R S Reneman; P J van der Starre
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

5.  Cibenzoline attenuates systolic anterior motion of the mitral valve after mitral valvoplasty.

Authors:  Takeshi Omae; Akira Matsunaga; Naka Imakiire; Ryuzo Sakata; Yuichi Kanmura
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

6.  Catecholamine stress alters neutrophil trafficking and impairs wound healing by β2-adrenergic receptor-mediated upregulation of IL-6.

Authors:  Min-Ho Kim; Farzam Gorouhi; Sandra Ramirez; Jennifer L Granick; Barbara A Byrne; Athena M Soulika; Scott I Simon; R Rivkah Isseroff
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.